top of page
  • Writer's pictureNammi Therapeutics

Amgen and BioLabs LA Announce Nammi Therapeutics to Receive the Third Amgen Golden Ticket

Amgen and BioLabs LA at The Lundquist Institute today announced that Nammi Therapeutics has been awarded the third Amgen Golden Ticker in Southern California. Nammi Therapeutics will receive one year of lab space at Biolabs LA as well as additional facility benefits and connections to Amgen scientific and business leaders.

The Amgen Golden Ticket winner was chosen by a team of Amgen scientific leaders at a virtual pitch event. Five finalists pitched their business plans before Amgen's internal committee that evaluated the strength and novelty of their scientific rationale, subject matter expertise, and business plan viability. View the file below for the full article.

Amgen Golden Ticket 01-06-2023
Download PDF • 744KB

129 views0 comments

Recent Posts

See All


bottom of page